|Videos|May 2, 2023
Interview with Jubilant’s President Chris Preti
Author(s)Jubilant
Key Learning Objectives:
- Progress on previously announced $285 million expansion plan will double capacity for sterile injectables fill/finish at Jubilant HollisterStier’s Spokane, Wash. Facility
- Strengthen’s Jubilant HollisterStier’s position in addressing contract manufacturing needs of major producers throughout North America
- Jubilant HollisterStier is a leading contract manufacturer of sterile injectables, ophthalmics, optics, sterile and non-sterile topicals and liquids
Related Content
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Danish Biotechs Attracting Investor Attention
3
Three Formats, One Platform: Halo's New Sterile Fill-Finish Line
4
CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda
5